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ABSTRACT 
The object of this research was to' isolate and purify 
Moloney and WMl-B strains of Murine Leukemia virus from 
{NIH) Swiss mouse embryo tissue culture and to determine 
transfer ribonucleic acid presence for Lysine and Arginine. 
Viruses were purified by ultracentrifugation and_ activity 
determined by Plaque Assay. Protein concentration and 
RNA content by Lowry and Orcinol assays respectfully, 
concludes a 2-3% total RNA content of this RNA tumor 
virus, similar· to that reported for Avian tumor viruses 
and other strains of Murine Leukemia viruses. Enzymatic 
am1noacylat1on proved that Murine Leukemia viruses con­
tain transfer RNA populations. This is the first time 
transfer RNA amino acid accepting activity in Murine 
Leukemia virus has been observed and may be a general 
property of RNA TumoT Viruses. 
-rNTRODUC'I'ION
-one of the biological functions of transfer ribo­
nucleic acid (tRNA) is to accept an amino acid.with the 
formation of a tRNA-amino acid derivative. The genetic 
code specified by the messenger ribonucleic acid (mRNA) 
ensure that the amino acid the tRNA carries is.correctly 
placed in sequence in the growing polypeptide chain. Cell­
ular tRNAs are transcribed from the deoxyribonucleic acid 
(DNA) in the nucleus, and after enzymatic modifications, 
active tRNA mol�cules are formed. Transfer RNA has recent-
ly been found in some species of RNA tumor viruses. RNA 
tumor viruses have been demonstra�ed to contain substan-
tial amounts of heterogenous populations of 4S .. RNA mole-
cules in addition to the single-stranded, 60-70S RNA 
genome. Many of the 4S RNA species have the properties of 
tRNA a� demonstrated by a� aminoacylation assay. Exam­
ination of the viral 4S RNA demonstrate methylation 
patterns of mod if led bas_es indicative of tRNA species. 
Resistance of the viral tRNA to RNAse tre�tment of intact 
v1r1ons clearly establishes that the tRNA is a component of 
the virus and not a contaminate of cellular tRNAs attached 
to the outside envelope. 
Avian tumor virus, an iNA tumor virus, has been 
found to contain tRNAs capable of accepting ea�h·of the 
20 amino acids. Murine Leukemia viruses have also been 
shown to have similarities to Avian tumor viruses in mode 
of infection, budding processes, maturation, mo.lecular 
weight, density centrifugation studies, and may contain 
all of the tRNA amino acid acceptor activities. found in 
the Avian strains. 
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The purpose of this study is to demonstrat� that 
Moloney and WMl-B strains of Murine LeukeI!lia virus contain 
lysine and arginine am1�o acid accepting tRNAs. After 
growth in (NIH) Swiss mouse embryo tissue c�lture, viruses 
were isolated and purified by ultracentrifugation. Total 
viral RNA was extracted and by an am1noaeylat1on,assay, 
lysine and arginine transfer RNAs were found to be present 
in both Moloney and WMl-B strains of Hurine Leukemia virus. 
The tRNAs present in these RNA tumor viruses are 
either specific viral. tRNAs or are present in.the virus 
due to fin incorporation of randomly selected hos.t-cell 
tRNAs when viral assemblies bud from the plasma membrane. 
Ree�nt stu�ies with Avian tumor viruses have shown tha� 
these tRNA species are different from cellular tRNAs. 
This. may also be true for Mur.ine Leukem1� viruses. 
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LITERATURE REVIEW 
One of the maJo,r roles of transfer ribonucleic acid 
(tRNA) 1n the cell ls the transfer of activated ,amino acids 
to the site of protein synthesis in the ribosome (1). In 
recent investigations �ther functions of tRNA have been 
observed. Among these. participation of tRNA in the bio­
synthesis of the interpeptlde bridges in the peptidoglycan 
of bacterial cell walls ( 2) and the amlnoacylat.lon of phos­
phatidylglycerols {J).
Transfer RNA has also been found in some RNA tumor 
viruses (�.5.6). Total viral RNA contains a l��ge single­
stranded 60-70S genome and a smaller 4S component(?). 
Some of.this heterogen�us 4s component has properties sim­
ilar to tRNA, exh1b1t1ng amino acid acceptor a�t1v1ty, 
chromatographic properties similar to cellul�r aminoacyl­
tRNA and can transfer amino acids to peptides C.5) in an 
in vitro protein synthes�zing system. Viral 4S.RNAs 
contaln charaeter1st1c methylated bases (8) which are re­
ported to be quantitatively different from cellular tRNAs 
( 9,) • 
Of the three presently known classes of oncornaviruses, 
or RNA .tumor viruses: Avian tumor viruses (ATV),Murine 
tu..�or viruses (Mu'I'V). and Mur1ne mammary tumor viruses 
(MMV) (10), the avian strains are the most studied. Sim­
ilarities do occur between the three classes of RNA tumor 
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viruses (11). Basic biological and struetural properties 
such as natural behavior. prevalence and modes of infection 
{ 12) occur. ATV• MuTV and MMV all contain single-stranded 
RNA which sediments between 69 and 74s (lJ). This RNA 
strand comprises approximately 2% of virus dry weight (14) 
containing J-4 pieces of J or� X 106 daltons each (15).
Electron microscopy indicates an electron-dense inner core 
ahd a 9ompressible outer viral envelope. 'This envelope is 
acquired from host plasma membranes as virus assembly is 
completed and budding occw:-s releasing an active virus 
.(lJ). Density gradient centri(ugation studies have shown 
that Murine Leukemia virus band at a density rahge of 1.15-
1.17 g/ml { 16,17)·. This is consistent With ·the values 
reported for Rous Sarcoma Virus (18), Avian Turn.or Viruses 
(19) and Murine Mammary"V1rus (20).
Polyacrylamide gel electrophoresis indicates that RNA
tunor' viruses pos·sess between five and seven major struct­
ural proteins. Similarities between Avian. and Mammalian 
viruses would therefore indicate �nalagous protein compo­
sition (16). Several enzymes are also associated wfth RNA 
tumor viruses. Adenosine.tr1phosphatase (21). ribonuclease 
(22), RNA-dependent DNA-polymerase (23). DNA ligase and 
ll\ 
exonuclease activities (24) and more recently aminoacyl-
tRNA synthetases (25) have been found 1n ATV. 
Avian Leukosis virus, a strain of ATV, has.·been demon­
strated to contain viral 4s RNAs capable of accepting 
almost all of the amino acids ( 19.26,27) •. Rous Sarcoma 
and Rous Associated viruses also contain 4S RNA·(28). 
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This 4s RNA contains aminoacyl acceptor activi�y indicating 
-,. 
that the presence of tRNA may be a general characteristic 
for Avian tumor viruses. 
In order to assay for tRNA, relatively large quanti­
ties ( mg) of purif led virus are usually r�quired { 28) •· 
ATV low molecular weight (LMW) RNAs are easily obtained 
;from chicken myeloblasts previously 1nocula._ted with virus 
( 29). Little was known about MuLV strains until the 
·development of in vitro tissue culture assay systems {30).
Previous studies of MuLV have been obtained by:animal ino-
culation, with production of leukemias in mice or rats as
the end point. In order for RNA tumor viruses to transform
host-cell, a specifec virus-specified DNA sequ�nce is pre-
s�ably integrated into the host-cell DNA molec'ule (10).
As cellular metabolism proceeds. viral-specific messages
are decoded, either by specific viral tRNAs or cell'ular
tRNA populations (31). The discovery of viral tRNA pop­
ulations in ATV (4,5,6) indicate that tRNA species are
carried by the viral assemblies, either as specific viral
tRNAs or incorporated cellular tRNAs.
It became apparent that similarities between RNA tu�or 
viruses would suggest general characteristics for all 
species. For t.his reason 1t is to be expected that tRNA 
may also be present in all RNA tu�or viruses. The pur-
pose of this investigation was to determine whe.ther or 
not tRNA populations are present in MuLV. The. strains 
investigated were Moloney and WMl-B. 
10 
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MATERIALS AND METHODS 
Tissue Cultures 
All cultures were grown and maintained in �ediu� 
consisting of Eagle's M1ni:nal Essential MediUI!l (ME�I) (32} 
with 10% unheated fetal calf serum, 2 mM glutamine, 10,000 
U/ml penicillin and 10,000 microgram/ml streptomycin. All 
tissue culture reagents were purchased from Grand Island 
Biological Co., Grand Island, New York. 
Primary Cultures Cell cultures were prepared from 
1)-15 day old embryos of Swiss Webster mice. The pregnant 
females were obtained from Microbiological Associates Inc., 
Bethesda, Maryland. Fr1mary cultures were prepared as 
previously described (JO). Embryos were �inced and placed 
into 40 ml of trypsin-EDI'A solution (0.5 g trypsin and 0.2 
g EDTA/liter of sal1?"J.e) and stirred for 8 minu�·es. The 
supernatant containing lysed red blood cells and cellular 
·-
debris was poured off and 40 ml trypsin-EDTA solution was
add�d and stirred for 20 mi�utes. The solution was filter­
ed through 4 X 4 gause, centrifuged in clinical centrifuge
and supernatant discarded. The pellet wa� resuspended in
10 ml of Eagle's HEM. Two ml aliquots were add�d to each
of five 32 oz. prescription bottl� containing 15 ml of
Eagle's MEM. Each bottle was gased with 95% air/5% co2
mixture for 2-J minutes and placed into an incubator at 
37°c. These mouse e�bryo tissue cultures were referred to 
as pri�ary �ouse e�bryo cells. Cell cultures were given 
gased air/CO2 mixture and the mediu.� was changed every 
two days. 
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Secondary Cultures After six days of growth, medium 
was poured off and 3 �l of tryps1n-EDTA was added. After 
1 minute this was poured off and an additional 5 ?ni 
trypsin-EIYI'A was added. The cell cultures were placed 
into an incubator at 37°c until cells were released. The 
cells were collected by centrifugation and resuspended in 
40 ml Eagle's !.YEH. Each primary culture bottle contained 
J-4 X 10 7 cells. Into each of ten 32 oz. prescription
· bottles we placed J-4 X 106 cells and 15 �l E�gle's MEi.
Cells were gased with air/CO2 mixture for 2-3 minutes and
0placed into an incubator at 37 c. �ediu.� was changed and
cells were gased with air/CO2 inixture every two days.
These mouse embryo cultures were referred to a$· secondary
mouse embryo tissue cultures, and were used for the growth
and __ assay of Moloney and WMl-B viruses. The cultures con­
sisted chiefly of fibroblasts.
Virus Innoculation and Collection Moloney and WMl-B 
virus stocks were originally obtained from Dr. Wallac� P. 
Rowe, National Institute of Health (NIH),"and were sub­
sequently grown in this laboratory. Moloney and WMl-B 
virus stock contained 5 X 105 PFU/�l (Plaque For�ing Units 
per �l) and 5 X 106 FFU/ml respectfully. On the second 
day of secondary mouse e�bryo cultures, mediu11 was poured 
off and JO �l fresh �ediu� was added. Cultures·were in-
noculated with 1 ml of Moloney or WEl-B virus s,tock per 
32 oz. prescription bottle and �ased with air/CO2 mixture. 
Cultures were pla.ced. in an incubator and maintained. at. 
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37° C. Virus containing med.iut!l was collected every 24 hours
for six days and stored at -20°c. A total of 900 ml for 
each virus preparation was collected. 
Plaque As say A modified plaque assay procedure with-
out DEAE-dextran pretreatment was followed as described by 
Rowe {JJ). After six days growth, 3-4 X 105 primary mouse 
embryo cells we:re placed into s·ixteen 60 X 15 mJ11 Falcon tis­
sue culture dishes containing 3 ml Eagle's MEN.· Cultures 
were place� into Hotpack Incubator at 37°c and �ased with
9_5% air/5% CO 2 mixture for 5 minutes. After 24 hours, serial 
dilutions of Moloney or WNl-B virus strains wel."e innoculated .;. 
into these secondary mouse embryo cultures. After five days 
incubation, the cells were irradiated. with ultra.violet li_g:ht .  
(25 seconds at 60 ergs/mm2/second) giving a total of 1500
ergs/mm2 • UV irradiation eliminated the mouse embryo cells. 
After irradiation the infected cells were overlaid with ap­
proximately 106 XC cells. XC cells are a rat tumor cell
originally induced by the Prague strain of Rous·Sarcoma 
virus. They were obtained originally from Wallace F. Rowe 
and carried continuously in the la�oratory. The medium was 
changed every two days and gased with air/CO 2 mixture. The 
cultures were fixed with metranol and �tained with hema­
toxylin on the 5th day a�ter XC cell addition. �he nur.i.ber 
of syncytiums .per petri disb were counted and recorded. 
Syncytium formation is directly proportional to viral 
concentration. 
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Virus Purification The isolation and purification of 
RNA tuc11or viruses has been described previously. by Robinson 
( 18) and was used with only slight modification. All steps
were carried out at 0-4°c. After low-speed centrifugation 
in a Sorvall R_C2-B refr�gerated centrifuge at 7,000 X g
for 10 minutes, am::ioniU!ll sulfate was added .to s_upernatant 
to obtain a 50% saturation. The solution was kept at about 
pH 7 by the addition of 1 M sodiµm hydroxide,. ·( approximate­
ly 10� ul./10 grams of (NH4) 2so4) After stirring for 45
�inutes on ice the precipitate was collected by centrifu-
gation at 11,000 X g·for 20 minutes. The supernatant was 
discarded and the precipitated virus was redissolved in 
buffer {0.01 M TRIS-Cl pH 7.5; 0.1 M sodium chloride; 
0.001 M ethylenediaminotetraacetic acid - TNE buffer). 
Aft�r low-speed centrifugation of s.ooo X g fo�. 10 minutes 
to re�ove insoluble protein, the supernatant was carefully 
layered on top of a 10 ml sucrose pad of 2 ml 65.% and 
8 ml 20$ w/v in TNE buffer. After centrif.ugat1on in 
sw-25.1 rotor at 2.5K for 2.5 hours at 4°c in Beckman Model 
LJ-50 Ult�acentrifuge, the virus banded at the 20-65% 
sucrose interface. One-half ml fractions were collected by 
puncturing the bottom of the tube. Virus containing ali� 
quots (usually the first 5-6 fractions) were diluted with 
approxi�ately 2 voluries of TNE buffer and carefully layered 
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onto preformed density grad lent of sucrose. ( 25-65%) 1n TNE 
buffer. Further centrifugation in the sw-25.1 rotor at 
25K ·and 4°c for 18 hours .resulted in a broad band of virus 
in the lower 1/3 of the tube.· One-half ml fractions were 
collected by puncturing bottom of tube. The protein con­
centr�tion for each frac�ion was d�termined by the method 
of Lowry et al (34) using bovine serum albumin as standard. 
The refractive index of the fractions was also determined 
using an Abbe Refractometer and the refractive index values 
recorded and converted to densities usi�g publi'shed con­
version tables (35). Protein containing fractions were 
collected and the virus was pelleted by centrifugation in 
the Ti-50 rotor at 50K and 4°c for l hour. The virus 
pellet was then resuspended in TNE buffer and stored at 
-20°c.
Isolation of Total Viral RNA Total viraL·RNA was 
isoiated by a procedure (18) previously described. The 
virus suspension (approximately 0.5 ml) was treated with 
50 ul. of 10% sodium. dodecyl sulphate and 0.5 ml water 
saturated phenol. After shaking at room te�perature for 
several minutes, the �1xture was centrifuged at.10,000 X g 
for 10 minutes. The aqueous layer was removed �nd the 
phenol _layer was again extracted with an equal volu�e of 
TNE buffer. To the co:n.bined aqueous layers was added 0.1 
volumes of 20% sodi�� acetate pH 5.4 and 2.5 volu�es 95% 
ethanol. Total viral RNA precipitated overnight at -20°c.
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The precipitate was collected by centrifugation. on Sorvall 
RC2-B at 15,000 X g and o0c for 20 minutes and resuspended 
in 0.5 Ml distilled water. Orcinol deter�ination was used 
to calculate the total amount of RNA obtained using the 
Dischi-Schwar method (36) and E. Coli RNA as st�ndard. 
Isolation of Cellular tRNA Cellular tRNA was pre-
pared from uninfected se.condary { NIH) Swiss Webster strain 
mouse e�bryo celi cultures. The procedure was �ssentially 
that for viral. RNA extraction. Trypsinized cell cultures 
were centrifuged and the pellet disrupted by, 10% sodiu:n  . 
dodecyl sulfate and water saturated phenol. �fter centri­
fugation. the aqueous layer was reextracted with equal 
volume of 0.1 M TRIS-Cl buffer. To the coCTbined superne­
tants 0.1 volumes 9f 20% sodiu� acetate pH 5.4 and 2.5 
volumes 95% ethanol were added and allowed to precipitate·­
overnig�t at -20°c. A pellet was collected by c�ntrifug­
atiqn at 10,000 X g and o0c for 10 minutes. The pellet 
was dissolved in 3 ml <>f 0.1 M TRIS-Cl buffer. pH 7.5 and 
centrifuged in Sorvall RC2-B at 10.000 X g and o0c for 10 
minutes for removal of any insoluble material. The super­
natant was loaded onto a 1 X 4 cm DEAE-cellulose. column 
after first equilibrating with 30-40 ml 0.1 M TRIS-Cl buf-
fer, pH 7.5 containing 0.1 M sod�um chloride. Colu�n was 
rinsed with 0.1 M.TRIS-Cl buffer, pH 7.5 and 0.1 M sodiu� 
chloride until absorbance at 260 nm decreased to less then 
0.05. One r:11 fractions were eluted when 0.1 M TRIS-Cl bu.f-
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fer, pH 7.5 containing 1.5 frI sodium chloride was added and 
absorbance at 260 n� was recorded. Fractions qpntaining 
high A260 values were combined and 2.5 volu�es of 95%
ethanol was added and allowed to precipitate ov.ernight at 
-20°c. After centrifugation in S�rvall RC2-B �t 15,000 X g
for 20 minutes, the pellet was resuspended in o .• 5 ml a is-
. 0
tilled water and stored at -20 c. Absorbance at 260 ren
and 280 nm was recorded.
Aminoacyl-tRNA Synthetase The procedure .for 1sola-
tion of aminoacyl-tRNA synthetases was essentially the sa-ne 
as that described by Barnett (37). All steps were carried 
(?Ut at o-5°c. ·confluent uninfected Swiss Webster strain 
secondary mouse embryo tissue cultures of 6 days·were 
scraped off and homogenized in a Dounce tissue grinder .(10 
strokes) with 5 �1 of Buffer A {0.01 M TRIS-Cl,. pH 7.5;
0.01 M ammonium chloride; 0.001 M· magnesiu� chloride; 0.02 
M 2-mercaptoethanol and 10% glycerol). After centrifugation 
in Sorvall RC2-B at 13,000 X g and o0c for 10 minutes, the 
supernatant was renoved and its pellet was rehomogenized 
with 5 ml Buffer A and centrifuged. The combined superna-
tants were loaded. onto a 1 X 4 c:a DEAE-cellulose column 
previously equilibrated with Buffer A. The colu.�n was 
washed.with Buffer A until the absorbance at 280 ?1!Il de-
creased to less than 0.05. The tRNA synthetases were then 
eluted from the colu�n with Buffer A containin�·0.25 M 
a�'TI.onium chloride. Two 1!11 fractions were collected. The 
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absorbance at 280 �� was recorded and the fractions con­
taining high protein concentrations were combined and 
dialyzed against Buffer A containing 200 grar.1s/liter car­
bowax 6000. When the volu�e of the protein decreased to 
1-2 ml, the dialyzing bag was re�oved and then .�ialyzed
against Buffer A for 8 hours. The final volu�e was brought
to 50% glycerol and stored at -20°c.
Assay of Amino Acid Accepting Activity RNA was 
aminoacylated in a 0.1 ml reaction mixture containing. 10 
,. 
umoles sodiu� cacodylate, pH 7.2; 0.2 umoles ATP; 1 umole 
KCl; 1 umole Mg ac�tate; l UC PH] labeled amino acid 
(specific activity range of 20-50 Ci/mmole}; RNA and syn­
thetase preparation. Reaction mixtures were incubated at 
37°c and 0.02 ml aliquots were precipitated on·Whatman ;MM 
filter discs in cold 5% trichloroacetic acid {38) at various 
times after incubation. Discs were washed 3 ti�es in 5%
trichloroacetic acid for 15 minutes each time, .once .in 
ethanol-ether mixture (1:1) and finally in ether for 10 
minutes. The dried filter discs were counted in Omnifluor 
{New England Nuclear) in a Packard Tricarb Liquid Scintil­
lation counter. 
19 
RESULTS 
The results of this study reported below will demon­
strate that Moloney and W�11-B strains of Murine ,Leukemia 
virus contain transfer ribonucleic acids caps.bl� of accept-
1ng the amino acids lysine and arginine. To da'te experi-
ments with other a�ino acids have not been performed. 
Virus Purification The results of the. first 25K
ultracentrifugation in a linear sucrose gradient show virus 
banded in a broad area approximately 2-3 mm wide on top of 
the heavier 65% sucrose layer. This band was collected in 
3-6 fractions, and after 18 hours of ultracentr_ifugation in
a sucrose density gr�dient, appeared in an opaque band 1/3 
from the bottom of the tube. The entire tube was collected ;;.,. 
in 0.5 ml fractions by puncturing the bottom of··,the tube •.. _ 
Each virus preparation contained 50-54 fractiona. 0.025 ml 
aliquots of each fraction were assayed for prot�in concen­
tratio� using the method of Lowry et al (34). Figure 1A 
shows a typical Lowry viral protein concentration curve 
f.rom Moloney viral preparation II. As indicated, fractions 
22-44 contain high amounts of protein relative to the rest
of the fractions. M,inor peaks in fractions 6-16 have also 
been reported for other RNA tumor 1'Viruses and ar_e probably
ribonucleoproteins from the viral envelope (39,40). Figure 
1B shows similar protein concentration for WMl-B' viral 
preparation Ill. 
Its clear that viral protein concentrations fro-n these 
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Figure 1: Density Gradient Centrifugation of Mur1ne 
Leukemia Viruses. 
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two independent preparations are similar in sedir.ientation 
qualities. Percent sucrose and refractive ind.ex for frac­
tions preceeding and following the viral protein band were 
checked on a refractometer. Table I indicates the conver-
sion from percent sucrose to density in grams/ml (35) for 
preparation III of the WMl-B strain. Table II shows the 
virus preparation from five independent e�periments. This 
data is similar with that reported for Avian tn�or virus 
(16) having a density of 1.15-1.17 g/crl. and other .reported
strains of MuLV having densitie·s of 1.16 g/ml C'l 7). Its 
clear from the centrifugation studies with Moloney and 
WMl-B strains that the protein bands represent ;solated 
viruses with consistent densities st�rting at 1.15-1.17 g/ml. 
Protein bands range from 1.17-1.05 g/crl. 
Plague Assay Moloney and WMl-B virus preparations 
were assayed to establish biological activity and to show 
that the protein bands did indeed contain viruses. The 
plaque assay techniques described by Rowe (JJ} and coworkers 
establish activity, cytopathic end point and titration 
parameters expressed in plaque forming untts per ml 
(PFU/�l). Purified virus suspensions were serially diluted 
into Eagle's MEM, according to the dilutions shown in 
'J 
Table I.II. 
-TABLE I
Refractive Index-Percent Sucrose-Sucrose Density 
WMl-B Virus Preparation III 
Fraction No. E.D %sucrose Densitl sLml I 
1. 1.4582 67.1 · 1.328
3. 1.4463 61.9 1.297
5. 1.4)24 55.8 1.261
7. 1.4325 55.8 1.261
9. 1.4.301 54.7 · 1.254
11. 1.419? 49.9 1.229
13. 1.4095 44.9 .1.202 
- 15. 1.4102 45.3 1.205 
17. 1.3956 37.9 1.166 
19. 1 • .3880 33.8 1.145 
45. 1.3527 13.2 1.051 
47. 1.3471 9.5 1.0.35 
49. 1.J4JO ,S.8 · 1.024
22 
·,
23 
-TABLE II
Density of Moloney and .WMl-B Freparat�ons 
Moloney · WMl-B 
Prep. I Prep. II Prep. I Prep. II Prep. III 
·Fractions
containing 19-41
Viral band
Refractive
22-44 18-40
Index 1.395- 1.393- 1.399- 1.398- ;• 
range 1.357 1.353 1.354 1.360 
Fercent
sucr..ose
range
Density
g/ml
range
3s�1s J1-1J 39-14
1.16- 1.1�- 1.17-
1.06 1.05 1.05 
39-19 ,·
1.1?-· 
1,08 
20-44
1.390-
1.353 
J4-1J 
1.15-·
1.05 
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Table III
Serial Dilution Factors for Plaque Assaz 
Dilution Dilution Factor Notation 
0.025 ml Virus + 2.5 ml Med iurn. 10
2 A 
0.2 ml A + 1.8 ml mediu.'11 103 B 
0.1 I!ll B + 9.9 ml mediU!D. 10
5 
C 
0.1 ml C + 9.9 ml medium 10
7 
D 
0.1 r.tl D + 9.9 ml mediu1ll 10
9 E 
0.1 ml E + 9.9 ml medium 10
11 
F 
From each dilution 0.1 ml was 1nnoculated into tissue 
culture dish as described in "methods." Syncytium for-· 
�ation by the XC cells for each culture dish was counted 
' -
and recorded. Table IV illustrates the results for Moloney 
preparation II and WMl-B preparation I. These results 
indicate that the procedure for viral isolation and purl-
. .
fication produces viruses in biologically active form cap-
able of producing focal areas of infection with (N1H) Swiss 
Webster strain mouse e�bryo cells and causing syncytium 
formation by the XC cells. 
Protein and Total RNA Deter�ination From Lowry and 
Orcinol determinations of the Moloney and W�11-B strains, 
sinilarities between each preparation were observed. The 
results of RNA and protein determination of several ·virus 
preparations is given in Table v.
Table IV 
Syncytium Formation by XC Cells 
Notation Dilution 
Moloney Frep. II A 102 
B 103 
C 105 
D 107 
E 109 
10
11 
control 
WMl-B Prep.I A 102 
B 103 
C 105 
D 107 
E 109 
F 10
11 
control ':i 
25 
No. Formed 
. 200+ 
··' 112 
8 
1 
ND 
ND 
. ., 
ND 
. 200+ 
101 
11 
4 
1 
ND 
ND 
F 
26 
Table V 
Protein and. Total RNA Content of Leukemia Viruses 
Moloney W�l-B 
Prep. I Frep. II Prep. I Prep. ·:tr Prep. III 
total ug. 
162 469 of protein 199 ,522, 399 
total ug. 
of RNA 94 88 75 16J 150 
ug. of RNA 
per mg. 
of protein 578 438 160 312 J76 
These values compair favorably with Beard (.41) for all 
RNA tUi!lor viruses. 
A�irioacylation of Total Viral RNA In order to demon-·�· -· 
·strate that a portion of the viral RNA in Moloney and WMl-B 
strains of MuLV. can accept radioactive a�ino acids, thus 
. . 
indicating a population of transfer RNAs·associated with 
the virus• an aminoacylation assay l(as utilized·; Two 
Moloney viral RNA, ,,and three WMl-B viral RNA preparations .... 
independently obtained were tested" ·ror their-·amino acid 
-. 
accepting ability with lys·1ne and arginine. The results- of 
these experiments are shown in Figures II and I�f • 
A su111nary o·r the aminoacylation experiments is given 
in Table VI. This table indicates the anount of a�ino 
acid attach�ent for lysine and arginine expressed in 
counts/�1nute {cp�). 
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Figure II 
.Lysine (a) Aminoacylation of- Viral RNA 
600 
400 
JH-cpm 
200 
( a) 
! b)
( c)
( d) 
•-------· 
• Unif .(b)
a 2X( c)
------ll-------:-B2X(d) .. _ 
o-------D------
---01X
0-----
0
---------------.,.. __ 00 RNA 
5 15 
Time in Minutes 
Specific activity for L-Lysi�e 
{New England Nuclear) 
is 
Uninfected cellular tRNA contains 
A-A WMl-B 2X contains 1.0 ug. of
f).-�W.,Il-B lX contains 0.5 ug. of 
•-• Moloney 2X contains o.·55 ug. 
o-o Moloney lX contains 0.25 ug.
.25
55C1/mmole 
1.4 ug. 
RNA 
RNA 
df RNA 
pf RNA 
.. ----------A.--------~-Cl 1X 
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Figure III 
JOOO 
2000 
3H-cpm
1000 
Arginine (a) Aminoacylation of Viral RNA 
.�:�•Un1f.(b) 
A A 2X( c) 
b. 
• 
0 
5 
A 
• 
------ 0 
0 
15 
Time in minutes 
b.lX 
B 2X( d) 
DlX 
oo RNA 
25 
(a) Specific activity for L-Arg1n1ne is 27C1/mmole
(New England Nuclear)
(b) Uninfected cellular tRNA contains 1,4 ug.
� 
( c) A-A. WMl-B 2X contains 1.0 ug. of RNA
b.-b. WMl-B lX contains 0.5 ug. of RNA
(o) 11-a"'!oloney 2X contains ,0.55 ug. of RNA
D - O >1oloney lX contains O. 25 ug. of RNA
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Table VI 
A ttachnient of JH-A'"'lino Acids t'o tRNA" 
Isolated from Moloney and WMl-B Viruses 
Moloney W't·H-B 
Prep. I Prep. II PJ."ep. I Prep. II Prep. III 
Total 
Viral 9.38 8.75 7.5 16.3 12.0 
RNA ( ug) 
cpm 
4'_58 Lysine 138 272 457 263 
cpm/ug. 
RNA 15.8 31.1 50.8 16.1 38.1 
Lysine 
cpm 
Arginine 753 975 476 ·1166
cpm/ug. 
RNA 86.1 128.6 59.3 .. 97.1
.Arginine 
The data given 1n Figure II and ·rrr and in· Table VI· 
clearly indicate the presence of tRNA 1n Moloney and WMl-B 
strains· of MuLV. A quantitative summary of these results 
is given in Table VII. 
Table VII 
P1co�oles of Amino Acid Accepted/20 ug. of Total Viral RNA 
11\ 
Moloney Wi11-B 
Frep. I Prep. II Fre£. I Prep. II P:rep. III
Lysine 0.062 0.131 o.25� 0.068 0.1150 
Arginine 0.379 0.614 0.138 o.459
Table VII indicat.es the number of picbmoles of amino 
acid accepted per 20 ug. of �NA. All preparati9ns show 
JO 
an increase of the arginine amino acid acceptance compaired 
to lysine. The significance of this finding is.nor clear. 
Arginine tRNAs have also been reported to be in greater 
quantities than lysine tRNAs for Avian Myeloblastosis virus 
(25), but the reverse has been fou..�d in Rous'Sarcoma and 
Rous Associated viruses ( 28) • RNA isolated from WM.1-B 
virus preparation I has a greater amino acid accepting 
ability than the other preparat.ions. Again the·reason for 
this is not clear. 
Using the data presented in Table VII, the amount of 
tRNA present in total viral.RNA can be estimated. Approx­
imately O .06 picomoles of lysine tnNA is present in 20 ug. .,, � 
of total RNA. Assuming that all 20 amino acid acceptor tRNA 
species are present at the same level, then 20 X 0.06 = 1.2 
picomoles tRNA are present per 20 ug. of total viral RNA. 
Since the average molecular weight of ·tRNA is 2.6 X 104
daltons, 1.2 picomoles of tRNA is equal to 0.03 ug. There­
fore 0.03 ug. of tRNA are present in 20 �· of total viral 
RNA, or about O .15% of the viral RNA is tRNA. 
Table VIII shows total ug. of tRNA and the ·percent of 
tRNA in �he total RNA prepara�ions� This information is 
taken from Tables V and VII utilizing the calculations 
explained above. From this data it is estimated· that 
Moloney st::rains contain approxir!lately 0.012% Ly'sine and 
0.05% Arginine tRNAs. and WNl-B strains con:ain 0.02% Lysine 
31 
and 0.056.% Arginine tRNAs. 
Table VIII
ug. and Fercent of Ar,Q.'inine, Lysine tRNAs/Freparation 
Moloney WNl-B 
Frep. I frep. II Frep. I Prep. II Frep. III
Lysine 
U,12.'. tRNA 
x 10-3 7.0 1,4.4 24.o 13.9 30.0 
. ,• 
percent .007 .016 .OJ2 .009 .020 
Arginine 
ug. tR�A
X ·10- 44.5 67.5 28.1 86.1 
percent .047 .090 .020 .057 
If the above values are approximately cor�ect then 
the total tRNA content of Moloney and WMl-B RNA can be cal-
culated assuming that all 20 amino acid acceptor. tRNA 
spec1es are present at the same level. The average of the 
two Jl1oloney and three WMl-B preparations indicate O. 62.% and 
0.86% of the total RNA obtained is tRNA r�spectlvely. 
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DISCUSSION 
Total RNA· obtained from Moloney and W!l'fl-B s'trains of 
MuLV contain aI!lino acid acceptor activity for Lysine an1 
Arginine. These populations of tRNAs are not derived �ro� 
external contaminants, but are intrinsic components of 
Murine Leukemia viral assemblies. An important factor for . .• 
increased sensitivity of I>iuLV was the use .of' National 
. . 
Institute of Health (NIH) Swiss Webster str�in mouse embryo 
tissue cultures. Swiss embryo _tissue cultures have a much 
broader sensitivity and the incidence of spontaneous leu­
kemia caused by contaminate vi:rons are-minute ('33). Grad­
ient centrifugation in sucrose for both strains ... tested 
establish a 1.15-1.17 g/ml density for MuLV. These are 
similar to those reported for ATV and MMV. Biological act­
ivity of' viruses was indicated by a positive Pl�que Assay 
with XC cells. Syncytium formation by indicator XC cells are 
specific for MuLV" strains (33). This· phenomenon clearly 
indicates that the purif icat·ion techniques employed isolated 
active Mo"loney and Wr-11-B ·type C viruses. Total viral RNA 
extracted by phenol, sodium dodecyl sulfate procedure and 
assayed for amino acid acceptor activity, indicate consis­
tent presence of Lysine and Arginine tRNKs. 
Similarities �hat exist ber,ween RNA tumor viruses 
indicate that features present in one may also be present 
in another. The presence of tRNA species in ATV and, as 
shown in this investigation, MuLV would indicate a general 
J3 
characteristic for all RNA tu�or viruses. Given this 
fact concerning viral tRNA presence, two questions arise: 
1. the origin of viral tRNAs, and 2. function of viral
tRNAs. 
Although there is no direct evidence as to the origin 
of viral tRNAs, three hypotheses should be considered: 
1. the viral tRNAs are.incorporated fro� host-cell pools
and liberated when virus asse�blies infect 'new hosts, 2. 
tRNAs are specific viral coded species transcr�bed fro� 
the single-stranded 69-74S RNA geno�e, or J. rando� as­
sortments of cellular tRNAs are modified or deactivated 
inside viral assemblies. Recent studies (27,28) of the 
properties of viral and cellular tRNAs have shown ·that 
viral tRNAs do not seem to represent a random assortment 
of cellular tRNAs. The viral tRNAs differ from cellular 
tRNA populations in that the distribution of amino acid 
accepting tRNA species is different (26). In addition, 
the chromatographic properties of isoaccepting ·tRNA species 
is different in the cellular and viral tRNA populations. 
The proposal that there is a viral selection of cellular 
tRNAs during budding of the virus from the cell would 
i�ply a membrane tRNA population different from the cyto-
plasmic tRNA population. Recent investigations in this 
laboratory with rat liver membrane associated tRNAs sup­
port the idea of membrane associated populations of tRNAs 
(42). Whether the me�brane tRNA population is different 
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from the cytoplasmic tRNA population is as yet µnknown. 
The function of tRNA species in viral asse�blies is 
also unclear. Viral tRNA �ay play a regulatory role in 
protein synthesis after virus infection. 'J'he o.ncogenic 
properties of virus i�plies a continuous tra�sl�tional con­
trol of the host-cell protein synthesizing machinery. to 
produce viral-specific proteins.· Specific protein syn­
thesis may be necessary for the preservation, co1--ipletlon or 
function of so··,1e viral components. Therefore vi.r�l tRNAs 
may function in initial translation procedures. Another .. ,. . .. . 
function would. be for specidic tRNAs to play a role in the 
transcription of DNA product fro·n the geno:nic R�A by_ ser­
ving as a primer. 4s RNA �olecules are associated with 
the 35S subunits of the single-stranded RNA geno�e by 
hydrogen bonds, snd it is possible t�at they act as pri�ers 
for the synthesis of DNA by RNA-dependent· DNA-poly�erase 
and�as linkers holding together the 35s RNA subunits. The
presence of RNA-dependent DNA-polynerase 1n virus wpuld 
strengthen this aspect • .  
Nevertheless the presence of virai tRNAs tn ATV and 
as indicated 1n this �tudy. MuLV, 1s more than c��ual, and 
may, perhaps, 1n11cate a general property of all RNA tu�or 
viruses. 
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